标题 |
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody- drug conjugate, in patients with locally advanced or metastatic solid tumours: afirst-in-human, open-label, multicentre, phase 1 study
BL-B01D1,一种首创的EGFR-HER3双特异性抗体-药物偶联物,用于局部晚期或转移性实体瘤患者:一项首次人体、开放标签、多中心、1期研究
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 | 暂无链接,等待应助者上传 |